CERO THERAPEUTICS HOLDINGS, INC. Operating Lease, Liability, Noncurrent
CERO THERAPEUTICS HOLDINGS, INC. (CERO) had Operating Lease, Liability, Noncurrent of $218.31 thousand as of 2025-06-30, per its 10-Q filed 2025-08-22.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2026-04-15
- 2025-06-30: Operating Lease, Liability, Noncurrent $218.31K.
- 2025-03-31: Operating Lease, Liability, Noncurrent $461.58K.
- 2024-12-31: Operating Lease, Liability, Noncurrent $699.11K.
- 2024-09-30: Operating Lease, Liability, Noncurrent $771.52K.
| Period end | Operating Lease, Liability, Noncurrent |
|---|---|
| 2025-06-30 | $218.31K 10-Q · filed 2025-08-22 |
| 2025-03-31 | $461.58K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $699.11K 10-K · filed 2026-04-15 |
| 2024-09-30 | $771.52K 10-Q/A · filed 2024-11-20 |
| 2024-06-30 | $1.07M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $1.37M 10-Q · filed 2024-05-17 |
| 2023-12-31 | $1.58M 10-K · filed 2025-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |